Activity
-
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Comorbidities in Multiple Sclerosis: Effects on DMTs, the Treatment Team, and MoreHaving a higher burden of comorbidities is associated with greater disability progression and lower QoL, as well as increased healthcare utilization and mortality. -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Multiple Sclerosis, Parkinson's Research With National DatabaseFunds for the project were allocated in the spending bill signed by President Trump. -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Study: Salt consumption factors in multiple sclerosis development – UPI.comHigh salt consumption is one of the contributing factors in developing multiple sclerosis, according to a study. -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Multiple Sclerosis: New Research Aims to Identify a Disabling Disease Earlier – VTDiggerMultiple Sclerosis (MS) is a disabling central nervous system disease, which may result in a range of physical and cognitive problems. Globally, 2.3 million people live with multiple sclerosis. There is no cure. A recent study at The University of Vermont (UVM) identified misdiagnosis of MS as a problem with significant consequences for patients. Pilot … -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Biogen advances research to improve outcomes for patients with multiple sclerosisBiogen aims to identify new ways to manage and monitor multiple sclerosis (MS) disease progression and provide physicians with real-world evidence to help inform treatment decisions -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Environmental factors can trigger onset of multiple sclerosis — Israeli study | The Times of IsraelElevated salt concentrations and temperature may lead to harmful structural changes in protective neural membranes, Tel Aviv University researchers say -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Asthma medication could slow brain atrophy in progressive MS | MS International FederationA phase II clinical trial has shown ibudilast, a repurposed asthma medication, can slow down the rate of brain tissue loss in progressive MS by almost half compared to a placebo treatment. -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Emerging Therapies, Progressive MS, Wellness/Lifestyle and Other Research News from ECTRIMS Meeting : National Multiple Sclerosis SocietyThe latest about MS treatments, related legislation, updates on the Society, and people living with MS. -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
Multiple sclerosis: Healthful diet tied to lower riskAn Australian multicenter study found that those who ate more vegetables, fish, and other healthful foods had a lower risk of MS than those who ate less. -
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
#ECTRIMS2018 – Emerging MS Treatments Highlight Annual ConferenceRead about potential new treatments and work into multiple sclerosis, being detailed at ECTRIMS Oct. 10-12, of most interest to the National MS Society.
